North America $11.11 Billion Diabetic Shoes/Footwear Market Demand & Opportunity Outlook 2015-2021 - Research and Markets

DUBLIN, October 26, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "North America Diabetic Shoes/Footwear Market Demand & Opportunity Outlook 2021" report to their offering.

The diabetic footwear market in United States was valued at USD 1112.0 Million in 2015

The total population of diabetic patients in the U.S. has augmented from 5.5 million in 1982 to 22.0 million in 2014. Owing to this augmented growth of diabetic population, the risk of foot ulcers and neuropathy has also increased significantly in the previous few years.

The report studies the demand on the basis of inpatient and outpatient in the region which further has been granule to the country data. In addition to that, to understand the most profitable distribution mode in the region, the market for U.S., Canada & Mexico has been studied based on the online & offline channels. Offline distribution channels further have been studied into specialty store, clinics & street stores.

Diabetes is also one of the prominent causes of lower limb amputations in the U.S. At present, the U.S. is a home to around 2 million people surviving with amputations (limb losses) and according to an estimate around 185,010 limb losses occurs every year in the U.S. According to the Center for Disease Control and Prevention (CDC), it is estimated that one out of every three adults in the U.S. would suffer from diabetes by the end of 2050. With this rise in number of diabetic cases in the country, the risk of lower limb amputations would also soar in the future.

In order to reduce the chances of amputations caused by diabetes, there is a great need of taking proper feet care measures like wearing right kind of footwear by the people. These measures and practices would surely help to fuel the market of diabetic footwear in the region. The therapeutic/diabetic footwear market in Canada is anticipated to witness a continuous rise in the year-on-year (y-o-y) growth rate from 4.6% in 2015 to 6.5% in 2017. However, the diabetic shoes demand growth rate is expected to decline by 0.8 percentage points from 7.09% in 2020 to 6.3% in 2021.

Key Topics Covered:

1. List of Figures & Tables

2. Executive Summary6

3. Market Entry & Winning Strategy

4. Research Methodology

5. Global Diabetic Footwear Market Size and Forecast

6. Market Segmentation

7. Porter's Five Force Model Analysis

8. Industry Growth Drivers

9. Restraints

10. Risk Analysis

11. Competitive Landscape

- Aetrex Worldwide, Inc.
- DARCO International Inc.
- DJO Global Inc
- Dr. Zen Inc
- Drew Shoe Corporation USA
- Duna Srl
- Hong Kong Grace Shoes Development Co Ltd.
- Medline Industries
- Ortho Europe
- Podartis Srl
- Sigvaris
- Supad
- Thuasne

For more information about this report visit http://www.researchandmarkets.com/research/b295km/north_america

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets